ab63059, at 1/50 dilution, staining DDIT4 in formalin-fixed, paraffin-embedded human lung carcinoma tissue by immunohistochemistry. ab63059 was peroxidase-conjugated to the secondary antibody, followed by DAB staining.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DDIT4 antibody (ab63059)This image is courtesy of an anonymous Abreview
ab63059 staining DDIT4 in Human artery tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 20% serum for 60 minutes at 21°C; antigen retrieval was by heat mediation in a citrate buffer. Samples were incubated with primary antibody (1/20) for 16 hours at 4°C. A Biotin-conjugated Goat anti-rabbit polyclonal (1/250) was used as the secondary antibody.
Mendiola M et al. Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel. Oncotarget7:24217-27 (2016).
Read more (PubMed: 26992213) »
Cao JX et al. MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells. Cell Death Dis5:e1426 (2014).
Read more (PubMed: 25255219) »